Drugs / Polyene phosphatidylcholine injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03982225 | Jul 2019 → Oct 2022 | — | AMIpharm Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polyene phosphatidylcholine injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03982225 ↗ |
| Route | Subcutaneous | “Polyene Phosphatidylcholine S.C injection” NCT03982225 ↗ |